IV Therapy in Special Populations Flashcards
6 cards from real IV practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 IV Therapy in Special Populations flashcards as text
Which site is preferred for intraosseous (IO) access in emergency situations when IV access is unobtainable in a child?
Answer: Proximal tibia
The proximal tibia is the preferred IO access site in children because it is easily identified, has a flat surface, and is distant from the chest during CPR.
A patient receiving chemotherapy develops extravasation of doxorubicin (an anthracycline vesicant). Which antidote is indicated?
Answer: Dexrazoxane (Totect)
Dexrazoxane (Totect) is the FDA-approved antidote for anthracycline extravasation, working by inhibiting free radical-mediated tissue damage.
Why should IV medications be administered cautiously in patients with chronic kidney disease (CKD)?
Answer: Impaired renal clearance leads to drug accumulation and increased risk of toxicity
CKD impairs renal drug clearance, causing renally-cleared medications to accumulate to toxic levels if doses are not adjusted.
In a pregnant patient requiring IV therapy, which solution is recommended to avoid to prevent fetal harm?
Answer: Large volumes of hypotonic solutions like 0.45% NaCl administered rapidly
Rapid large-volume hypotonic IV fluid administration in pregnancy can cause maternal hyponatremia and neonatal hyponatremia/cerebral edema.
When managing IV therapy for an obese patient, which catheter-related challenge is most commonly encountered?
Answer: Difficulty visualizing and palpating veins due to adipose tissue, often requiring ultrasound guidance
Subcutaneous adipose tissue in obese patients obscures vein visualization and palpation; ultrasound guidance significantly improves first-attempt success rates.
Which precaution is most important when administering IV potassium chloride to a pediatric patient?
Answer: Never exceed recommended infusion rates and verify concentration limits to prevent cardiac arrest
IV potassium must be administered as a dilute solution at controlled rates because rapid or concentrated potassium infusion can cause fatal cardiac arrhythmias.
How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy
Sources & references
Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy
- ins1.org — Test delivery, eligibility, exam format, passing score, registration deadline, retake fee, retake policy, score release, score validity, test dates · verified Oct 2026